[ad_1]
The covid AstraZeneca vaccine “is safe and effective.” Today Italy, after the news of the green light from the EMA, begins to administer the doses of the drug produced by the Anglo-Swedish multinational. The go-ahead came yesterday afternoon, with the conference of experts from the European drug agency. After the stop, linked to the notification of thrombotic events, we started again. The AstraZeneca vaccine, says the EMA, “is not associated with an overall increased risk of thromboembolic events and blood clots.”
EMA
“Some countries have discontinued vaccines. The scientific conclusion we have reached gives countries the information to make an informed decision about using the AstraZeneca vaccine in their vaccination campaign,” said Emer Cooke, Executive Director of EMA. , reiterating that “its benefits and the protection of people against Covid-19 outweigh the possible risks.” Cooke then said that “we will initiate further research to understand more” about the “rare” adverse events reported after vaccination with AstraZeneca. “During the research and review activities” initiated in some reports, “we began to see a small number of cases of a rare and unusual but very serious bleeding disorder and this observation triggered a more focused review,” Cooke noted. The agency made available to the various states “the information to make a well-thought-out decision.” And Italy, today at 3 pm, will resume the administration of the vaccine.
DRAGHI
“The Italian government welcomes Ema’s pronouncement on the AstraZeneca vaccine. Administration of the Astrazeneca vaccine will resume on Friday.” The government’s priority continues to be to carry out the largest number of vaccines in the shortest time possible, “said Minister Mario Draghi.
AIFA
AIFA green light: “The reasons behind the preventive ban on the use of vaccine lots, issued on March 15, 2021, have disappeared. Therefore,” today “, as soon as the Committee for Medicinal Products for Human Use (CHMP) will issue its opinion, Aifa will revoke the ban on the use of the AstraZeneca vaccine, thus allowing a complete resumption of the vaccination campaign from 3:00 pm ”, announced the Italian Medicines Agency, after consulting the Minister of Health, the General Directorate of Prevention and the High Council of Health. ”In turn, communications from the individual regions have arrived announcing the imminent resumption of vaccines with the drug.
ASTRAZENECA
At the end of the day, the company notes: “There is no overall increased risk of thrombosis with Astrazeneca’s Covid-19 vaccine,” said AstraZeneca, noting that it will “continue to work closely with authorities. To ensure proper use of the vaccine. Vaccine for COVID-19 “. The multinational “recognizes and will implement the recommendations of the Prac (the Pharmacovigilance Risk Assessment Committee of Ema, ed), including updating the information on the product, continuing to understand the nature and relevance of these events to ensure that the administration sure of the vaccine to continue during this public health crisis. “
[ad_2]
